<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/8766</identifier>
				<datestamp>2023-11-07T00:33:35Z</datestamp>
				<setSpec>bovine:RA</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Effects of intranasal or parenteral respiratory vaccination administered on-arrival or delayed in auction-derived feedlot heifers</dc:title>
	<dc:creator xml:lang="en">McAllister, Hudson</dc:creator>
	<dc:creator xml:lang="en">Powledge, Sherri</dc:creator>
	<dc:creator xml:lang="en">Parks, Timothy</dc:creator>
	<dc:creator xml:lang="en">Streeter, Marshall</dc:creator>
	<dc:creator xml:lang="en">Hutcheson, John</dc:creator>
	<dc:creator xml:lang="en">Richeson, John</dc:creator>
	<dc:subject xml:lang="en">beef heifers</dc:subject>
	<dc:subject xml:lang="en">intranasal</dc:subject>
	<dc:subject xml:lang="en">parenteral</dc:subject>
	<dc:subject xml:lang="en">vaccine</dc:subject>
	<dc:description xml:lang="en">The objective was to evaluate health, performance and serum antibody responses of auction-derived heifers to an intranasal or parenteral MLV administered on d 0 or 28. Three arrival blocks of heifers, initial BW = 459 lb ± 1.7 lb (208 kg ± 27kg; n = 600), were randomly assigned to treatments consisting of 15 pens/treatment with pen as the experimental unit and 10 heifers/pen. Treatments were: 1) Bovilis® Nasalgen® 3 and Bovilis® Vista® BVD on d 0 (NAS0); 2) Bovilis® Vista® 5 SQ on d 0 (VIS0); 3) Bovilis® Nasalgen® 3 and Bovilis® Vista® BVD on d 28 (NAS28); 4) Bovilis® Vista® 5 SQ on d 28 (VIS28). Body weight and blood samples were collected on d 0, 28 and 56. Activity (351.4 vs 354.3 min/d) and rumination time (282.6 vs 285.4 min/d) was less (P &amp;lt; 0.01) for delayed vs arrival vaccinated heifers. A timing χ vaccine χ day interaction existed (P &amp;lt; 0.01) for BRSV- and IBRV-specific antibody titers; VIS28 had the greatest (P &amp;lt; 0.01) BRSV antibody titer on d 56. For IBRV antibody titer on d 28, VIS0 was greatest, NAS0 was intermediate, and VIS28 and NAS28 were least (P &amp;lt; 0.01). Percentage of chronically ill heifers were reduced for arrival vs delayed (1.3 vs 4.7%; P = 0.02) and arrival vaccinated had a reduction in antimicrobial treatment cost ($4.63 vs $7.31; P = 0.02). Data indicate improvement in some health outcomes for the parenteral route and arrival timing of MLV, but performance was not affected.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2023-11-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8766</dc:identifier>
	<dc:identifier>10.21423/bovine-vol57no1p49-59</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 57 No. 1 (2023); 49-59</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8766/8509</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2023 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
